GETINGE, Sweden--(BUSINESS WIRE)-- Regulatory News:
Getinge (STO:GETIB) announced today that it is rescheduling its Capital Markets Day for a later date to be announced. This decision was made based on very recent communications with the U.S. Food & Drug Administration (FDA), which are the subject of active discussions.
Getinge Group will hold its Capital Markets Day when it has more to report about these discussions, their potential financial impact on the company, and the latest progress being made in strengthening Medical Systems’ quality management systems.
Getinge apologizes to those who had made plans to attend the Capital Markets Day and are inconvenienced by the rescheduling.
As announced earlier, the Medical Systems business area has been in a dialogue with the FDA to ensure that efforts made to strengthen its quality management system fully meet the FDA’s requirements based on a series of inspections that took place last year. The enhancements at Medical Systems are well under way and are expected to be completed during the second half of 2015, and, as previously disclosed, costs for these efforts are expected to amount to approximately SEK 800 million and were charged to the first quarter results of 2014.
This announcement will be followed by a conference call at 10.00 AM CET tomorrow, hosted by Johan Malmquist, CEO Getinge Group and Ulf Grunander, CFO Getinge Group.
To participate, please call:
Sweden: +46 (0)8 5853 6965
UK: +44 (0)20 3427 1914
US: +1 646 254 3361
09.45 Call the conference number
11.00 End of conference
A recorded version of the conference will be accessible for five working days at the following number:
Sweden: +46 (0)8 5051 3897
UK: +44 (0)20 3427 0598
US: +1 347 366 95 65
The Getinge Group is a global leading medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. The Group is divided into three business areas: Medical Systems, Extended Care and Infection Control and operates under the brands ArjoHuntleigh, Getinge and Maquet.
This information was brought to you by Cision http://news.cision.com
Phone: +46 10 335 5810
Source: Getinge Group